Literature DB >> 10851365

Age-specific incidence rates of Alzheimer's disease: the Baltimore Longitudinal Study of Aging.

C Kawas1, S Gray, R Brookmeyer, J Fozard, A Zonderman.   

Abstract

OBJECTIVE: To estimate age-specific incidence rates of AD in the Baltimore Longitudinal Study of Aging (BLSA).
BACKGROUND: The BLSA is a volunteer cohort of normal subjects followed longitudinally with biennial evaluations at the Gerontology Research Center of the National Institute on Aging.
METHODS: Subjects are 1236 participants (802 men, 434 women) in the BLSA with longitudinal follow-up between January 1985 and May 1998. The average length of follow-up was 7.5 years, with participants evaluated every 2 years by physical, neurologic, and neuropsychological examinations. Using Diagnostic and Statistical Manual of Mental Disorders, 3rd ed., revised and National Institute of Neurological and Communicative Disorders and Stroke-Alzheimer's Disease and Related Disorders Association criteria, the authors diagnosed dementia and AD.
RESULTS: The authors diagnosed 155 cases of dementia, of which 114 (74%) were AD. Incidence rates of AD increased with age from an estimated 0.08% per year (95% CI 0.00 to 0.43) in the 60 to 65 age group to an estimated 6.48% per year (95% CI 5.01 to 8.38) in the 85+ age group for men and women combined. The doubling time of incidence rates was estimated to be approximately 4.4 years and the median time of conversion from mild cognitive impairment to diagnosis of AD was estimated to be 4.4 years. There was a trend for women to have higher incidence rates than men and for fewer years of education to be associated with higher incidence rates; however, these effects were not significant.
CONCLUSION: Incidence rates for AD in the BLSA are consistent with published rates in other studies. The longitudinally followed subjects of the BLSA offer a unique opportunity to prospectively investigate the antecedents of AD.

Entities:  

Mesh:

Year:  2000        PMID: 10851365     DOI: 10.1212/wnl.54.11.2072

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  163 in total

1.  Longitudinal magnetic resonance imaging studies of older adults: a shrinking brain.

Authors:  Susan M Resnick; Dzung L Pham; Michael A Kraut; Alan B Zonderman; Christos Davatzikos
Journal:  J Neurosci       Date:  2003-04-15       Impact factor: 6.167

Review 2.  The role of insulin resistance in the pathogenesis of Alzheimer's disease: implications for treatment.

Authors:  G Stennis Watson; Suzanne Craft
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

Review 3.  Hormonal influences on cognition and risk for Alzheimer's disease.

Authors:  Sarah C Janicki; Nicole Schupf
Journal:  Curr Neurol Neurosci Rep       Date:  2010-09       Impact factor: 5.081

4.  Cerebral blood flow by arterial spin labeling in poststroke dementia.

Authors:  M J Firbank; J He; A M Blamire; B Singh; P Danson; R N Kalaria; J T O'Brien
Journal:  Neurology       Date:  2011-04-26       Impact factor: 9.910

Review 5.  Prevention of Alzheimer's disease: where we stand.

Authors:  Mary Sano
Journal:  Curr Neurol Neurosci Rep       Date:  2002-09       Impact factor: 5.081

6.  Cognitively normal individuals with AD parents may be at risk for developing aging-related cortical thinning patterns characteristic of AD.

Authors:  Katherine Reiter; Kathryn I Alpert; Derin J Cobia; Mary J Kwasny; John C Morris; John C Csernansky; Lei Wang
Journal:  Neuroimage       Date:  2012-04-05       Impact factor: 6.556

7.  Age, Alzheimer's disease and dementia in the Baltimore Longitudinal Study of Ageing.

Authors:  David Dolan; Juan Troncoso; Susan M Resnick; Barbara J Crain; Alan B Zonderman; Richard J O'Brien
Journal:  Brain       Date:  2010-07-20       Impact factor: 13.501

8.  Depressive symptoms, symptom dimensions, and white matter lesion volume in older adults: a longitudinal study.

Authors:  Joshua W Kirton; Susan M Resnick; Christos Davatzikos; Michael A Kraut; Vonetta M Dotson
Journal:  Am J Geriatr Psychiatry       Date:  2013-10-11       Impact factor: 4.105

9.  Expression of Iron Transporters and Pathological Hallmarks of Parkinson's and Alzheimer's Diseases in the Brain of Young, Adult, and Aged Rats.

Authors:  Li-Na Lu; Zhong-Ming Qian; Ka-Chun Wu; Wing-Ho Yung; Ya Ke
Journal:  Mol Neurobiol       Date:  2016-08-30       Impact factor: 5.590

Review 10.  The Potential of Gonadal Hormone Signalling Pathways as Therapeutics for Dementia.

Authors:  X Du; R A Hill
Journal:  J Mol Neurosci       Date:  2016-08-15       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.